S'abonner

Treponema pallidum detection in lesion and non-lesion sites in men who have sex with men with early syphilis: a prospective, cross-sectional study - 25/08/21

Doi : 10.1016/S1473-3099(20)30838-0 
Janet M Towns, PhD a, b, , David E Leslie, MBBS c, , Ian Denham, MBBS a, Rebecca Wigan, MPH a, Francesca Azzato, BSc(Hons) c, Deborah A Williamson, ProfPhD d, e, f, Darren Lee, BSc e, Eric P F Chow, PhD a, b, g, Christopher K Fairley, ProfPhD a, b, Stephen R Graves, ProfPhD h, Lei Zhang, PhD a, b, i, j, Marcus Y Chen, ProfPhD a, b
a Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia 
b Central Clinical School, Faculty of Nursing, Medicine and Health Sciences, Monash University, Melbourne, VIC, Australia 
c Victorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia 
d Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia 
e Department of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia 
f Department of Microbiology, Royal Melbourne Hospital, Melbourne, VIC, Australia 
g Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia 
h Australian Rickettsial Reference Laboratory, Barwon Health, Geelong, VIC, Australia 
i China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, Shaanxi, China 
j Department of Epidemiology and Biostatistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China 

* Correspondence to: Dr Janet Towns, Melbourne Sexual Health Centre, Carlton, VIC 3053, Australia Melbourne Sexual Health Centre Carlton VIC 3053 Australia

Summary

Background

Syphilis transmission is increasing, and precisely how Treponema pallidum is transmitted sexually from person to person is unclear. We aimed to determine the frequency of T pallidum shedding from potentially asymptomatic sites and the stage of infection at which shedding is most frequent in men who have sex with men (MSM), who have been disproportionately affected by syphilis.

Methods

We did a prospective, cross-sectional study in MSM recruited from Melbourne Sexual Health Centre (Melbourne, VIC, Australia). Men were eligible if they were aged 18 years or older, reported sex with men during the past 12 months, and had laboratory confirmed primary, secondary, or early latent syphilis, consistent with Australian definitions. Primary and secondary syphilis lesions were swabbed and non-lesion samples were collected via oral rinse, oral cavity swab, anal canal swab, urine, and semen. Samples were tested for T pallidum using PCR assays targeting polA (lesion and non-lesion samples) and 47 kDa (non-lesion samples only) gene targets. The primary outcome was the proportion of men with T pallidum detected from potentially asymptomatic sites—namely, the mouth, anus, urethra, and semen.

Findings

Between Nov 30, 2015, and May 23, 2019, 246 MSM were screened for inclusion, of whom 200 had serologically confirmed early syphilis and were included in the study: 54 (27%) of 200 had primary syphilis, 93 (47%) had secondary syphilis, and 53 (27%) had early latent syphilis. T pallidum DNA was detected in 48 (24%; 95% CI 18·3–30·5) of 200 men by oral rinse or oral lesion swab, or both, of whom 24 had no oral lesions. Oral T pallidum detection was most frequent in those with secondary syphilis compared with those at other stages of disease (41 [44%] of 93 vs seven [7%] of 107; p<0·0001), and in men with rapid plasma reagin titres of 1/64 or higher compared with those with lower titres (37 [32%] of 117 vs 11 [13%] of 83; p=0·0026). T pallidum was detected by anal canal swab or anal lesion swab, or both, in 45 (23·0%; 95% CI 17·3–29·5) of 196 men with available samples, of whom ten had no anal lesion. Furthermore, T pallidum was detected in urine samples of 12 (6·1%, 3·2–10·3) of 198 men and in semen samples from six (12·0%, 4·5–24·3) of 50 men who provided samples. Among the 93 men with secondary syphilis, 69 (74%) had T pallidum detected at any site, and 24 (26%) had detection at two or more separate sites. Among the 54 men with primary syphilis, 49 (91%) had T pallidum detected at any site, and 11 (20%) had detection at two or more separate sites. Among the 53 men with early latent syphilis, four (8%) had T pallidum detected at any site and none had T pallidum detected at two or more separate sites.

Interpretation

Unrecognised oral and anal shedding of T pallidum occurs in MSM with early syphilis, most frequently in those with secondary syphilis, suggesting secondary syphilis is the most infectious stage and that earlier detection and treatment of syphilis to prevent progression to the secondary stage might improve syphilis control. Future research is needed to ascertain the contribution of shedding of T pallidum from non-lesion sites to transmission of syphilis.

Funding

Australian National Health and Medical Research Council.

Le texte complet de cet article est disponible en PDF.

Plan


© 2021  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 21 - N° 9

P. 1324-1331 - septembre 2021 Retour au numéro
Article précédent Article précédent
  • Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial
  • Bruno François, Hasan S Jafri, Jean Chastre, Miguel Sánchez-García, Philippe Eggimann, Pierre-François Dequin, Vincent Huberlant, Lucia Viña Soria, Thierry Boulain, Cédric Bretonnière, Jérôme Pugin, Josep Trenado, Ana Catalina Hernandez Padilla, Omar Ali, Kathryn Shoemaker, Pin Ren, Frank E Coenjaerts, Alexey Ruzin, Olivier Barraud, Leen Timbermont, Christine Lammens, Vadryn Pierre, Yuling Wu, Julie Vignaud, Susan Colbert, Terramika Bellamy, Mark T Esser, Filip Dubovsky, Marc J Bonten, Herman Goossens, Pierre-François Laterre, COMBACTE Consortium and the SAATELLITE Study Group, Didier Chochrad, Alain Dive, Frédéric Foret, Marc Simon, Herbert Spapen, Jacques Creteur, Yves Bouckaert, Patrick Biston, Marc Bourgeois, Martin Novacek, Tomas Vymazal, Petr Svoboda, Jan Pachl, Vladimir Sramek, Michal Hanauer, Tomas Hruby, Martin Balik, Tomas Suchy, Alain Lepape, Laurent Argaud, Frédéric Dailler, Arnaud Desachy, Christophe Guitton, Alain Mercat, Ferhat Meziani, Jean-Christophe Navellou, Rene Robert, Bertrand Souweine, Jean-Marc Tadie, Adel Maamar, Djillali Annane, Fabienne Tamion, Antoine Gros, Saad Nseir, Carole Schwebel, Gilles Francony, Jean-Yves Lefrant, Francis Schneider, Matthias Gründling, Johann Motsch, Lorenz Reill, Caroline Rolfes, Tobias Welte, Oliver Cornely, Frank Bloos, Maria Deja, Katrin Schmidt, Frank Wappler, Andreas Meier-Hellmann, Apostolos Komnos, Vasileios Bekos, Vasilios Koulouras, Ioanna Soultati, Georgios Baltopoulos, Georgios Filntisis, Epaminondas Zakynthinos, Spyros Zakynthinos, Ioannis Pnevmatikos, Ildikó Krémer, Zoltán Szentkereszty, Agnes Sarkany, Zsuzsa Marjanek, Pedro Moura, Maria Consuelo Pintado Delgado, Juan Carlos Montejo González, Paula Ramirez, Antonio Torres Marti, Juan Carlos Valia, Jose Lorente, Ana Loza Vazquez, Raúl De Pablo Sanchez, Dolores Escudero, Ricard Ferrer Roca, Jean-Luc Pagani, Marco Maggiorini
| Article suivant Article suivant
  • Cryptococcal meningoencephalitis: time for action
  • Katharine Elizabeth Stott, Angela Loyse, Joe N Jarvis, Melanie Alufandika, Thomas Stephen Harrison, Henry C Mwandumba, Jeremy N Day, David G Lalloo, Tihana Bicanic, John R Perfect, William Hope

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.